Strong evidence from clinical and basic research indicates ... Vascular dementia; MS, Multiple sclerosis; LB, Lewy bodies; DLB, Dementia with Lewy bodies; PDD, Parkinson’s disease dementia; TDP-43, ...

The drug, LL-341070, enhances the brain's ability to repair damaged myelin— the protective sheath around nerve fibers. Damage to myelin is a hallmark of diseases like MS, as well as a natural ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases in Munich, Germany is the winner of the 2024 Barancik Prize for Innovation ...

Multiple sclerosis (MS) is a chronic inflammatory condition that damages the protective sheath (myelin) around nerve fibers. It can also damage the nerves themselves. When myelin and nerves in ...

Multiple sclerosis (MS) causes neurological ... is a manufactured substance that resembles a basic protein of natural myelin. It’s thought to work by prompting the WBCs to attack the substance ...

A selective GPR17 (G protein-coupled ... with an initial focus on multiple sclerosis (MS). Demyelination in MS occurs when the immune system attacks and damages the myelin sheaths that insulate ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring ... Scientists believe glatiramer acetate mimics a protein found in myelin and distracts your immune system from ...

has been awarded this year’s $125,000 Barancik Prize for his extensive research on myelin, a protective coating that sheathes nerve cells and becomes damaged in multiple sclerosis (MS).

The drug, LL-341070, has demonstrated remarkable potential to accelerate the brain's ability to repair damaged myelin—the ... common symptoms of multiple sclerosis include: - Fatigue - Muscle ...

In multiple sclerosis (MS), a person's immune system attacks the protective covering (myelin sheath) of nerve fibers in the brain and spinal cord (central nervous system). MS disease-modifying ...

Multiple sclerosis (MS) is a chronic, neurodegenerative autoimmune disease targeting the myelin sheath of primarily the central ... A 5% DMSO solution in normal saline (0.9% w/v sodium chloride) ...